The National Health Act (1953) has recently been amended to implement measures announced as part of the PBS Access and Sustainability package. This includes removing the originator brand from price disclosure calculations.

More information on the amendments to the Act and explanatory material can be found on the Parliament of Australia website.

A table of PBS drugs on the F2 formulary and brands which it is proposed may be determined as originator brands (under subsection 99ADB(6B) of the Act) is available on the PBS website.

For more details, go to: http://www.pbs.gov.au/news/2015/07/originator-list-files/originator-list-for-pbs-medicines-on-f2-formulary-stakeholder-consultation.pdf